TerminatedNot Applicable

Treatment of Type I Supracondylar Fractures of the Humerus

Stopped: We were unable to recruit the appropriate numbers as parents did not want to randomize their child for the treatments options.

Canada12 participantsStarted 2009-05

Plain-language summary

Type I supracondylar fractures are elbow fractures that occur in children aged 3-10 years. Many different treatment options exist to treat this type of fracture. The purpose of this study is to compare three different treatment modalities with regards to pain experienced during treatment, the amount of pain medication needed during treatment, and any short-term complications. We hypothesize that above elbow casting and long-arm splinting will result in less pain and have fewer complications than taping the elbow in flexion.

Who can participate

Age range4 Years – 12 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patients aged 4-12 years who present to the Emergency department at BC Children's hospital with a history of elbow trauma, and are diagnosed by the staff emergency physician to have a Type I supracondylar fracture of the humerus (as seen on AP and lateral radiographs of the elbow) Exclusion Criteria: * patients with neurovascular compromise associated with the fracture * a pre-existing diagnosis of metabolic or structural bone disease that predisposes them to fractures * presence of other fractures of the ipsilateral upper extremity

What they're measuring

Mean pain intensity and median pain duration over treatment period

Timeframe: 3 weeks

Trial details

NCT IDNCT00904137

SponsorUniversity of British Columbia

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2014-01

View on ClinicalTrials.gov More Type I Supracondylar Fracture of the Humerus trials